SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899923-24-000026
Filing Date
2024-05-08
Accepted
2024-05-08 08:14:50
Documents
91
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-20240331.htm   iXBRL 10-Q 910186
2 EX-31.1 exhibit311-certificationof.htm EX-31.1 10436
3 EX-31.2 exhibit312-certificationof.htm EX-31.2 10434
4 EX-32.1 exhibit321-certificationpu.htm EX-32.1 6100
  Complete submission text file 0000899923-24-000026.txt   6485177

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20240331.xsd EX-101.SCH 53227
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20240331_cal.xml EX-101.CAL 73735
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20240331_def.xml EX-101.DEF 219677
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20240331_lab.xml EX-101.LAB 651359
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20240331_pre.xml EX-101.PRE 446485
95 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20240331_htm.xml XML 907088
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 24924355
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)